CHU de Clermont-Ferrand
Clermont-Ferrand, 63000, France
NCT Number: NCT04917536
The aim of the study is to show if there is any speed difference of functional recovery for people with humeral fracture, treated by an anterograde nail, which will be inserted through the rotator cuff (the common way) or through the rotator interval split.
The patients included in this study will be randomized to one of the two groups.
The recovery will be evaluated by the Constant score over time, for a year. The main hypothesis is the rotator interval split approach allows a faster functional recovery after humeral nailing, by avoiding opening the rotator cuff.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Clermont-Ferrand, 63000, France
Humeral fractures are the third most common fractures over 65 years and represent 8% of all fractures. The anterograde nailing is known to be an efficient way to treat humeral upper extremity fractures and humeral diaphysis fractures. The main complications of this nailing are pain, shoulder stiffness, rotator cuff tendinitis and impingement.
Studies have proven these problems can be due to the entry portal of the nail. Indeed, it is inserted through the supra-spinatus tendon, which means an opening of the rotator cuff even if it is closed at the end of the procedure.
But the rotator interval split in the shoulder can allow to insert the nail through it without opening the cuff or damaging the cartilage. It is located between the anterior side of the supra-spinatus tendon and the posterior side of the long part of the biceps.
The aim of the study is to compare the speed of functional recovery according to the entry portal, which are through the rotator cuff or through the rotator interval split, in humeral fractures treated by anterograde nailing.
The cutaneo-muscular approach will be the same in both groups, namely a trans-deltoid approach.
People will be included in the study after an enlightened and signed consent, afterward they will be randomized to one of the two groups.
To evaluate the primary outcome, the Constant Score will be used to measure the kinetic of the recovery.
The secondary outcomes are residual pain (measured by the VAS an evaluation of complications and a radiological review (two different reviewers) to follow the healing and search any side effects, the sick leave and rehabilitation durations.
The patients need to be available for a one-year follow-up. Each assessment will be checked at 21 and 45 days, and at 3, 6 and 12 months after the surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Humeral neailling in humeral fractures
Time frame: Day 21
Measured by the objective Constant score (absolute and weighted values), which includes an evaluation of the pain, level of daily activities, use of the hand, range of motion and strength. The collected data will allow us to draw a diagram to compare the speed of recovery. Its values are between 0 (bad) and 100 (good)
Time frame: Day 45
Measured by the objective Constant score (absolute and weighted values), which includes an evaluation of the pain, level of daily activities, use of the hand, range of motion and strength. The collected data will allow us to draw a diagram to compare the speed of recovery. Its values are between 0 (bad) and 100 (good)
Time frame: Month 3
Measured by the objective Constant score (absolute and weighted values), which includes an evaluation of the pain, level of daily activities, use of the hand, range of motion and strength. The collected data will allow us to draw a diagram to compare the speed of recovery. Its values are between 0 (bad) and 100 (good)
Time frame: Month 6
Measured by the objective Constant score (absolute and weighted values), which includes an evaluation of the pain, level of daily activities, use of the hand, range of motion and strength. The collected data will allow us to draw a diagram to compare the speed of recovery. Its values are between 0 (bad) and 100 (good)
Time frame: Month 12
Measured by the objective Constant score (absolute and weighted values), which includes an evaluation of the pain, level of daily activities, use of the hand, range of motion and strength. The collected data will allow us to draw a diagram to compare the speed of recovery. Its values are between 0 (bad) and 100 (good)
Time frame: Day 21
subjective test showing any difficulties in the daily living activities, relationships, and evaluating the pain and tingling; all of these items are based on the week before the assessment. It ranges from 0 to 100 more the value is better brought up is the score.
Time frame: Day 45
subjective test showing any difficulties in the daily living activities, relationships, and evaluating the pain and tingling; all of these items are based on the week before the assessment. It ranges from 0 to 100 more the value is better brought up is the score.
Time frame: Month 3
subjective test showing any difficulties in the daily living activities, relationships, and evaluating the pain and tingling; all of these items are based on the week before the assessment. It ranges from 0 to 100 more the value is better brought up is the score.
Time frame: Month 6
subjective test showing any difficulties in the daily living activities, relationships, and evaluating the pain and tingling; all of these items are based on the week before the assessment. It ranges from 0 to 100 more the value is better brought up is the score.
Time frame: Month 12
subjective test showing any difficulties in the daily living activities, relationships, and evaluating the pain and tingling; all of these items are based on the week before the assessment. It ranges from 0 to 100 more the value is better brought up is the score.
Time frame: day 21
a subjective score to evaluate what kind of activity is actually possible for the patient
Time frame: day 45
a subjective score to evaluate what kind of activity is actually possible for the patient
Time frame: Month 3
a subjective score to evaluate what kind of activity is actually possible for the patient
Time frame: Month 6
a subjective score to evaluate what kind of activity is actually possible for the patient
Time frame: Month 12
a subjective score to evaluate what kind of activity is actually possible for the patient
Time frame: Day 21
Visual analog scale (VAS) : the pain is quantified by a number from 0 (no pain) to 10 (the worst pain ever known)
Time frame: Day 45
Visual analog scale (VAS) : the pain is quantified by a number from 0 (no pain) to 10 (the worst pain ever known)
Time frame: Month 3
Visual analog scale (VAS) : the pain is quantified by a number from 0 (no pain) to 10 (the worst pain ever known)
Time frame: Month 6
Visual analog scale (VAS) : the pain is quantified by a number from 0 (no pain) to 10 (the worst pain ever known)
Time frame: Month 12
Visual analog scale (VAS) : the pain is quantified by a number from 0 (no pain) to 10 (the worst pain ever known)
Time frame: day 0
Searching any early or late complications, such as neurological or vascular problems, haematoma, infection, dislocation, with a clinical exam or other possible paraclinical exams
Time frame: day 21
Searching any early or late complications, such as neurological or vascular problems, haematoma, infection, dislocation, with a clinical exam or other possible paraclinical exams
Time frame: day 45
Searching any early or late complications, such as neurological or vascular problems, haematoma, infection, dislocation, with a clinical exam or other possible paraclinical exams
Time frame: Month 3
Searching any early or late complications, such as neurological or vascular problems, haematoma, infection, dislocation, with a clinical exam or other possible paraclinical exams
Time frame: Month 6
Searching any early or late complications, such as neurological or vascular problems, haematoma, infection, dislocation, with a clinical exam or other possible paraclinical exams
Time frame: Month 12
Searching any early or late complications, such as neurological or vascular problems, haematoma, infection, dislocation, with a clinical exam or other possible paraclinical exams
Time frame: day 21
The patient is asked when he has returned to his professional activity
Time frame: day 45
The patient is asked when he has returned to his professional activity
Time frame: Month 3
The patient is asked when he has returned to his professional activity
Time frame: Month 6
The patient is asked when he has returned to his professional activity
Time frame: Month 12
The patient is asked when he has returned to his professional activity
Time frame: day 21
The patient is asked about the length of the physiotherapy.
Time frame: day 45
The patient is asked about the length of the physiotherapy.
Time frame: month 3
The patient is asked about the length of the physiotherapy.
Time frame: month 6
The patient is asked about the length of the physiotherapy.
Time frame: month 12
The patient is asked about the length of the physiotherapy.
Time frame: during the surgery and immediately after (Day 0)
any or no transfusion of blood cells
Time frame: during the surgery (Day 0)
time to perform the surgery collected from the operating file in minutes
Time frame: during the surgery and immediately after (Day 0)
haemoglobin levels in g/dl
Time frame: Day 45
consolidation or not
Time frame: Month 3
consolidation or not
Time frame: Month 6
consolidation or not
Time frame: Month 12
consolidation or not
University Hospital, Clermont-Ferrand
Other
Comparison Between the Entry Portals Through the Rotator Cuff and Through the Rotator Interval Split for Anterograde Humeral Nailing in Humeral Fractures: a Prospective Randomized Study
Acronym: HUNAAP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05943574
Arm Injuries, Fractures, Bone
Naples, Campania, Italy
View Trial DetailsNCT05118087
Arm Injuries, Fractures, Bone
Garden City, New York, United States
View Trial DetailsNCT05143476
Arm Injuries, Dystocia
Boston, Massachusetts, United States
View Trial DetailsNCT07368725
Arm Injuries, Fractures, Bone
Shijiazhuang, Heibei, China
View Trial Details